A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Israel

RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Asthma

Locations

Teva Investigational Site 12087, Phoenix, Arizona, United States
Teva Investigational Site 12144, Phoenix, Arizona, United States
Teva Investigational Site 12104, Tucson, Arizona, United States
Teva Investigational Site 12146, Tucson, Arizona, United States
Teva Investigational Site 12102, Little Rock, Arkansas, United States
Teva Investigational Site 12154, Encinitas, California, United States
Teva Investigational Site 12103, Huntington Beach, California, United States
Teva Investigational Site 12068, La Palma, California, United States
Teva Investigational Site 12152, Laguna Niguel, California, United States
Teva Investigational Site 12145, Long Beach, California, United States
Teva Investigational Site 12088, Los Angeles, California, United States
Teva Investigational Site 12094, Los Angeles, California, United States
Teva Investigational Site 12161, Northridge, California, United States
Teva Investigational Site 12105, Oxnard, California, United States
Teva Investigational Site 12101, Sacramento, California, United States
Teva Investigational Site 12064, San Jose, California, United States
Teva Investigational Site 12109, Upland, California, United States
Teva Investigational Site 12070, Vista, California, United States
Teva Investigational Site 12091, Walnut Creek, California, United States
Teva Investigational Site 12142, Lakewood, Colorado, United States
Teva Investigational Site 12098, Lake City, Florida, United States
Teva Investigational Site 12118, Lake Worth, Florida, United States
Teva Investigational Site 12079, Melbourne, Florida, United States
Teva Investigational Site 12071, Miami, Florida, United States
Teva Investigational Site 12074, Miami, Florida, United States
Teva Investigational Site 12086, Miami, Florida, United States
Teva Investigational Site 12061, Miami, Florida, United States
Teva Investigational Site 12097, Miami, Florida, United States
Teva Investigational Site 12092, Miami Lakes, Florida, United States
Teva Investigational Site 12076, North Miami Beach, Florida, United States
Teva Investigational Site 12095, Palmetto Bay, Florida, United States
Teva Investigational Site 12075, Pompano Beach, Florida, United States
Teva Investigational Site 12078, Tampa, Florida, United States
Teva Investigational Site 12175, Conyers, Georgia, United States
Teva Investigational Site 12156, Boise, Idaho, United States
Teva Investigational Site 12162, Westchester, Illinois, United States
Teva Investigational Site 12081, Nottingham, Maryland, United States
Teva Investigational Site 12106, Towson, Maryland, United States
Teva Investigational Site 12157, White Marsh, Maryland, United States
Teva Investigational Site 12119, Boston, Massachusetts, United States
Teva Investigational Site 12073, Minneapolis, Minnesota, United States
Teva Investigational Site 12066, Richfield, Minnesota, United States
Teva Investigational Site 12149, Columbia, Missouri, United States
Teva Investigational Site 12108, St Louis, Missouri, United States
Teva Investigational Site 12089, St Louis, Missouri, United States
Teva Investigational Site 12158, Hastings, Nebraska, United States
Teva Investigational Site 12160, Las Vegas, Nevada, United States
Teva Investigational Site 12150, Las Vegas, Nevada, United States
Teva Investigational Site 12110, Jersey City, New Jersey, United States
Teva Investigational Site 12167, Buffalo, New York, United States
Teva Investigational Site 12115, Charlotte, North Carolina, United States
Teva Investigational Site 12085, Raleigh, North Carolina, United States
Teva Investigational Site 12063, Toledo, Ohio, United States
Teva Investigational Site 12155, Tulsa, Oklahoma, United States
Teva Investigational Site 12170, Tulsa, Oklahoma, United States
Teva Investigational Site 12117, Clackamas, Oregon, United States
Teva Investigational Site 12151, Portland, Oregon, United States
Teva Investigational Site 12147, Horsham, Pennsylvania, United States
Teva Investigational Site 12072, Philadelphia, Pennsylvania, United States
Teva Investigational Site 12114, Pittsburgh, Pennsylvania, United States
Teva Investigational Site 12067, Columbia, South Carolina, United States
Teva Investigational Site 12111, Myrtle Beach, South Carolina, United States
Teva Investigational Site 12112, North Charleston, South Carolina, United States
Teva Investigational Site 12107, Rock Hill, South Carolina, United States
Teva Investigational Site 12083, Austin, Texas, United States
Teva Investigational Site 12060, Austin, Texas, United States
Teva Investigational Site 12077, Corsicana, Texas, United States
Teva Investigational Site 12159, Dallas, Texas, United States
Teva Investigational Site 12090, Dallas, Texas, United States
Teva Investigational Site 12143, El Paso, Texas, United States
Teva Investigational Site 12168, Houston, Texas, United States
Teva Investigational Site 12080, Kingwood, Texas, United States
Teva Investigational Site 12096, McKinney, Texas, United States
Teva Investigational Site 12113, Mesquite, Texas, United States
Teva Investigational Site 12084, Victoria, Texas, United States
Teva Investigational Site 12148, Pleasant View, Utah, United States
Teva Investigational Site 12082, Salt Lake City, Utah, United States
Teva Investigational Site 12153, South Ogden, Utah, United States
Teva Investigational Site 12093, Portsmouth, Virginia, United States
Teva Investigational Site 12062, Greenfield, Wisconsin, United States
Teva Investigational Site 20154, Buenos Aires, Argentina
Teva Investigational Site 20156, Buenos Aires, Argentina
Teva Investigational Site 20157, Córdoba, Argentina
Teva Investigational Site 20150, Córdoba, Argentina
Teva Investigational Site 20145, Mar del Plata, Argentina
Teva Investigational Site 20151, Mar del Plata, Argentina
Teva Investigational Site 20146, Quilmes, Argentina
Teva Investigational Site 20148, Rosario, Argentina
Teva Investigational Site 20155, Rosario, Argentina
Teva Investigational Site 20147, San Juan Bautista, Argentina
Teva Investigational Site 20152, San Miguel de Tucumán, Argentina
Teva Investigational Site 20149, San Miguel de Tucumán, Argentina
Teva Investigational Site 59248, Haskovo, Bulgaria
Teva Investigational Site 59251, Lovech, Bulgaria
Teva Investigational Site 59249, Montana, Bulgaria
Teva Investigational Site 59247, Pleven, Bulgaria
Teva Investigational Site 59256, Sliven, Bulgaria
Teva Investigational Site 59246, Sofia, Bulgaria
Teva Investigational Site 59252, Sofia, Bulgaria
Teva Investigational Site 59253, Sofia, Bulgaria
Teva Investigational Site 59245, Stara Zagora, Bulgaria
Teva Investigational Site 59254, Veliko Tarnovo, Bulgaria
Teva Investigational Site 59250, Vratsa, Bulgaria
Teva Investigational Site 54245, Jindřichův Hradec, Czechia
Teva Investigational Site 54244, Teplice, Czechia
Teva Investigational Site 54243, Varnsdorf, Czechia
Teva Investigational Site 32881, Ahrensburg, Germany
Teva Investigational Site 32880, Bendorf, Germany
Teva Investigational Site 32884, Berlin, Germany
Teva Investigational Site 32886, Berlin, Germany
Teva Investigational Site 32879, Frankfurt, Germany
Teva Investigational Site 32887, Leipzig, Germany
Teva Investigational Site 32883, Leipzig, Germany
Teva Investigational Site 32876, Leipzig, Germany
Teva Investigational Site 32877, Magdeburg, Germany
Teva Investigational Site 32878, Mainz A. Rhein, Germany
Teva Investigational Site 32888, Neu-Isenburg, Germany
Teva Investigational Site 32882, Rheine, Germany
Teva Investigational Site 80207, Be’er Ya‘aqov, Israel
Teva Investigational Site 80206, Haifa, Israel
Teva Investigational Site 80208, Jerusalem, Israel
Teva Investigational Site 21133, Chihuahua City, Mexico
Teva Investigational Site 21134, Mexico City, Mexico
Teva Investigational Site 21137, Morelia, Mexico
Teva Investigational Site 21136, Tlalnepantla, Mexico
Teva Investigational Site 21135, Zapopan, Mexico
Teva Investigational Site 53578, Gdansk, Poland
Teva Investigational Site 53575, Lodz, Poland
Teva Investigational Site 53576, Lodz, Poland
Teva Investigational Site 53579, Poznan, Poland
Teva Investigational Site 53574, Tarnów, Poland
Teva Investigational Site 53577, Wroclaw, Poland
Teva Investigational Site 52148, Craiova, Romania
Teva Investigational Site 52147, Oradea, Romania
Teva Investigational Site 52145, Timișoara, Romania
Teva Investigational Site 61090, Belgrade, Serbia
Teva Investigational Site 61093, Belgrade, Serbia
Teva Investigational Site 61092, Belgrade, Serbia
Teva Investigational Site 61088, Belgrade, Serbia
Teva Investigational Site 61094, Kragujevac, Serbia
Teva Investigational Site 61095, Novi Sad, Serbia
Teva Investigational Site 61091, Užice, Serbia
Teva Investigational Site 62102, Košice, Slovakia
Teva Investigational Site 62103, Martin, Slovakia
Teva Investigational Site 62101, Spišská Nová Ves, Slovakia
Teva Investigational Site 82089, Adana, Turkey (Türkiye)
Teva Investigational Site 82085, Kirikkale, Turkey (Türkiye)
Teva Investigational Site 82088, Kocaeli, Turkey (Türkiye)
Teva Investigational Site 82087, Mersin, Turkey (Türkiye)

View source on ClinicalTrials.gov Contact study team (email)